Market Place
Sourcing Support
EU Commission Grants Orphan Drug Status to Florbetaben (18F)
12 Jun 2025 //
PR NEWSWIRE
Life Molecular Imaging Gets ADDF Funding for Alzheimer’s PET
20 May 2025 //
PR NEWSWIRE
Life Molecular Imaging, SOFIE launch Neuraceq® in Albany, NY
20 May 2025 //
PR NEWSWIRE
Life Molecular Imaging announces Neuraceq® at PharmaLogic
24 Apr 2025 //
PR NEWSWIRE
Florbetaben (18F) Injection (Neuraceq) Launching at St. Teresa` Hospital
14 Mar 2025 //
PR NEWSWIRE
Life Molecular Imaging Gets FDA Fast Track For Cardiac Amyloidosis
21 Jan 2025 //
PR NEWSWIRE
Life Molecular & SOFIE announce Neuraceq availability in NJ
06 Jan 2025 //
PR NEWSWIRE
Life Molecular Imaging Announces Neuraceq® In Cincinnati, Oh
29 Oct 2024 //
PR NEWSWIRE
Life Molecular Imaging Gets FDA Fast Track For Tau PET Imaging
28 Aug 2024 //
PR NEWSWIRE
Life Molecular Imaging and PharmaLogic announce Neuraceq® availability in Denver
20 Aug 2024 //
PR NEWSWIRE
Life Molecular And Jubilant Announce Neuraceq Availability In Mobile, AL
09 Jul 2024 //
PR NEWSWIRE
Life Molecular Imaging and SOFIE announce Neuraceq® availability in Cleveland
05 Apr 2024 //
PR NEWSWIRE
Life Molecular Imaging and SOFIE announce Neuraceq® availability in Houston
09 Jan 2024 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.